Abstract
Manganese oxide supported on alumina and zirconia has been prepared by precipitation-impregnation method. The materials have been characterized by FT-IR, P-XRD, BET, TPD-NH3, TGA, SEM and TEM techniques for their textural properties. The catalytic activity of these materials has been explored in the synthesis of dihydropyrimidinones via.,Biginelli reaction. A rod like morphology is observed for zirconia containing 5% manganese oxide. These materials exhibited good catalytic activity in terms of isolated yield (>97%) and selectivity (100%) for the synthesis of dihydropyrimidinones. Acidity of the catalysts and the tetragonal phase of zirconia were found to play an important role in catalyzing this reaction. The catalyst with 5%Mn/ZrO2 exhibited distinctly different catalytic activity. The catalyst is reusable without losing its activity upto 5 cycles.
Keywords: Biginelli reaction, dihydropyrimidinones, manganese oxide on alumina/zirconia, role of acidity, solvent free synthesis.
Current Catalysis
Title:Catalytic Activity of Manganese Oxide Anchored on to Alumina and Zirconia for the Synthesis of Dihydropyrimidinones: Role of Acidity, Crystal Phase and Morphology
Volume: 3
Author(s): Mahadevaiah Rekha, Hagalahalli N. Hareesh, Nagaraju Kathyayini and Narasimaiah Nagaraju
Affiliation:
Keywords: Biginelli reaction, dihydropyrimidinones, manganese oxide on alumina/zirconia, role of acidity, solvent free synthesis.
Abstract: Manganese oxide supported on alumina and zirconia has been prepared by precipitation-impregnation method. The materials have been characterized by FT-IR, P-XRD, BET, TPD-NH3, TGA, SEM and TEM techniques for their textural properties. The catalytic activity of these materials has been explored in the synthesis of dihydropyrimidinones via.,Biginelli reaction. A rod like morphology is observed for zirconia containing 5% manganese oxide. These materials exhibited good catalytic activity in terms of isolated yield (>97%) and selectivity (100%) for the synthesis of dihydropyrimidinones. Acidity of the catalysts and the tetragonal phase of zirconia were found to play an important role in catalyzing this reaction. The catalyst with 5%Mn/ZrO2 exhibited distinctly different catalytic activity. The catalyst is reusable without losing its activity upto 5 cycles.
Export Options
About this article
Cite this article as:
Rekha Mahadevaiah, Hareesh N. Hagalahalli, Kathyayini Nagaraju and Nagaraju Narasimaiah, Catalytic Activity of Manganese Oxide Anchored on to Alumina and Zirconia for the Synthesis of Dihydropyrimidinones: Role of Acidity, Crystal Phase and Morphology, Current Catalysis 2014; 3 (1) . https://dx.doi.org/10.2174/2211544703999140130115808
DOI https://dx.doi.org/10.2174/2211544703999140130115808 |
Print ISSN 2211-5447 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5455 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mesenchymal Stromal Cells; Role in Tissue Repair, Drug Discovery and Immune Modulation
Current Drug Delivery Dendritic Cells in Colorectal Cancer and a Potential for their Use in Therapeutic Approaches
Current Pharmaceutical Design New Treatment Strategies for Multiple Myeloma by Targeting BCL-2 and the Mevalonate Pathway
Current Pharmaceutical Design Tyrosine Kinases as New Molecular Targets in Treatment of Inflammatory Disorders and Leukemia
Current Pharmaceutical Design Macrocyclic Inhibitors of HCV NS3-4A Protease: Design and Structure Activity Relationship
Current Topics in Medicinal Chemistry Hypersensitivity Reactions from Excipients in Systemic Glucocorticoid Formulations
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Vascular Pharmacotherapy and Dementia
Current Vascular Pharmacology Current Strategies and Future Directions for Eluding Adenoviral Vector Immunity
Current Gene Therapy Cardiac Remodeling Induced by Smoking: Concepts, Relevance, and Potential Mechanisms
Inflammation & Allergy - Drug Targets (Discontinued) Kynurenine Pathway in Schizophrenia: Pathophysiological and Therapeutic Aspects
Current Pharmaceutical Design The Role of COX-2 in Oral Cancer Development, and Chemoprevention/ Treatment of Oral Cancer by Selective COX-2 Inhibitors
Current Pharmaceutical Design Inhibition of Mitogen-Activated Protein Kinases (MAPKs) as a Strategy to Prevent Intimal Hyperplasia Following Cardiovascular Interventions
Vascular Disease Prevention (Discontinued) Novel Molecular Targets for the Prevention of Fetal Alcohol Syndrome
Recent Patents on CNS Drug Discovery (Discontinued) Peripheral Opioid Analgesia
Current Pharmaceutical Biotechnology Meet Our Editorial Board Member
Current Pharmaceutical Biotechnology Tumor Necrosis Factor-Alpha Monoclonal Antibodies for Crohns Disease: Tipping the Balance
Current Medicinal Chemistry Targeting Enzymes with Phosphonate-Based Inhibitors: Mimics of Tetrahedral Transition States and Stable Isosteric Analogues of Phosphates
Current Enzyme Inhibition Long Chain n-3 Polyunsaturated Fatty Acids in the Prevention of Allergic and Cardiovascular Disease
Current Pharmaceutical Design How to Make a Non-Antigenic Protein (Auto) Antigenic: Molecular Complementarity Alters Antigen Processing and Activates Adaptive-Innate Immunity Synergy
Anti-Cancer Agents in Medicinal Chemistry The Role of Lipids and Membranes in the Pathogenesis of Alzheimer's Disease: A Comprehensive View
Current Alzheimer Research